3-ALPHA-CHLORIMPERIALINE - AN M(2)-SELECTIVE MUSCARINIC RECEPTOR ANTAGONIST THAT PENETRATES INTO BRAIN

被引:6
作者
BAUMGOLD, J
PRYZBYC, RL
REBA, RC
机构
[1] GEORGE WASHINGTON UNIV,MED CTR,DEPT PHARMACOL,WASHINGTON,DC 20037
[2] UNIV CHICAGO,NUCL MED SECT,CHICAGO,IL 60637
关键词
MUSCARINIC RECEPTOR; MUSCARINIC RECEPTOR ANTAGONIST; SPECT (SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY) IMAGING; RADIOLIGAND;
D O I
10.1016/0014-2999(94)90417-0
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Muscarinic M(2) receptors have been found to be severely depleted in post-mortem brains of Alzheimer's patients. This loss of receptor may represent a useful diagnostic marker, if it could be quantitatively imaged with single-photon emission computed tomography (SPECT) or positron emission tomography (PET) imaging. In order to develop a radioligand with selectivity for muscarinic M(2) receptors, we now report that 3-alpha-chlorimperialine is a potent M(2) receptor antagonist with a K-i of 0.32 nM at M(2) receptors, a 12-fold selectivity for M(2) over M(1) receptors, and a 5-fold selectivity for M(2) over M(4) receptors. Furthermore, 2% of the injected dose of 3-alpha-chlorimperialine per gram tissue penetrates into brain within 30 min, then washes out gradually. Taken together, these studies demonstrate that 3-alpha-chlorimperialine is a potent M(2)-selective muscarinic antagonist that penetrates into brain and may be a useful substrate for radioiodination and subsequent imaging of brain muscarinic M(2) receptors.
引用
收藏
页码:315 / 317
页数:3
相关论文
共 11 条
[1]   COMPARATIVE ALTERATIONS OF NICOTINIC AND MUSCARINIC BINDING-SITES IN ALZHEIMERS AND PARKINSONS DISEASES [J].
AUBERT, I ;
ARAUJO, DM ;
CECYRE, D ;
ROBITAILLE, Y ;
GAUTHIER, S ;
QUIRION, R .
JOURNAL OF NEUROCHEMISTRY, 1992, 58 (02) :529-541
[2]   MUSCARINIC RECEPTOR SUBTYPE SELECTIVITY OF NOVEL HETEROCYCLIC QNB ANALOGS [J].
BAUMGOLD, J ;
COHEN, VI ;
PAEK, R ;
REBA, RC .
LIFE SCIENCES, 1991, 48 (24) :2325-2329
[3]   USE OF EXVIVO BINDING TO MEASURE THE BRAIN CONCENTRATIONS OF PUTATIVE RADIOLIGANDS [J].
BAUMGOLD, J ;
LING, PY ;
REBA, RC .
NUCLEAR MEDICINE AND BIOLOGY, 1992, 19 (05) :513-516
[4]   CHARACTERIZATION OF THE INTERACTION OF THE CERVANE ALKALOID, IMPERIALINE, AT MUSCARINIC RECEPTORS INVITRO [J].
EGLEN, RM ;
HARRIS, GC ;
COX, H ;
SULLIVAN, AO ;
STEFANICH, E ;
WHITING, RL .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1992, 346 (02) :144-151
[5]   A NOVEL M2-SELECTIVE MUSCARINIC ANTAGONIST - BINDING CHARACTERISTICS AND AUTORADIOGRAPHIC DISTRIBUTION IN RAT-BRAIN [J].
GITLER, MS ;
REBA, RC ;
COHEN, VI ;
RZESZOTARSKI, WJ ;
BAUMGOLD, J .
BRAIN RESEARCH, 1992, 582 (02) :253-260
[6]   MUSCARINIC ACETYLCHOLINE-RECEPTORS IN ALZHEIMERS-DISEASE - INVIVO IMAGING WITH IODINE 123-LABELED 3-QUINUCLIDINYL-4-IODOBENZILATE AND EMISSION TOMOGRAPHY [J].
HOLMAN, BL ;
GIBSON, RE ;
HILL, TC ;
ECKELMAN, WC ;
ALBERT, M ;
REBA, RC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1985, 254 (21) :3063-3066
[7]  
ITO S, 1976, TETRAHEDRON LETT, V36, P3161
[8]   MUSCARINIC RECEPTOR PROBES BASED ON AMINE CONGENERS OF PIRENZEPINE AND TELENZEPINE [J].
JACOBSON, KA ;
KARTON, Y ;
BAUMGOLD, J .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1992, 2 (08) :845-850
[9]  
LI M, 1991, MOL PHARMACOL, V40, P28
[10]   THE DISTRIBUTION OF CEREBRAL MUSCARINIC ACETYLCHOLINE-RECEPTORS INVIVO IN PATIENTS WITH DEMENTIA - A CONTROLLED-STUDY WITH 123IQNB AND SINGLE PHOTON-EMISSION COMPUTED-TOMOGRAPHY [J].
WEINBERGER, DR ;
GIBSON, R ;
COPPOLA, R ;
JONES, DW ;
MOLCHAN, S ;
SUNDERLAND, T ;
BERMAN, KF ;
REBA, RC .
ARCHIVES OF NEUROLOGY, 1991, 48 (02) :169-176